The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Psoriatic Arthritis Treatment-Global Market Insights and Sales Trends 2025
Synopsis
The global Psoriatic Arthritis Treatment market size is expected to reach US$ 12040 million by 2029, growing at a CAGR of 5.7% from 2023 to 2029. The market is mainly driven by the significant applications of Psoriatic Arthritis Treatment in various end use industries. The expanding demands from the Hospitals, Clinics, Ambulatory Surgery Centers and Diagnostic Laboratories, are propelling Psoriatic Arthritis Treatment market. Kits, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Reagents segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Psoriatic Arthritis Treatment, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Psoriatic Arthritis Treatment market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Psoriatic Arthritis Treatment market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Psoriatic Arthritis Treatment sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Psoriatic Arthritis Treatment covered in this report include Eli Lilly, Roche, Merck, Novartis, Abbvie, Amgen, Bristol Myers Squibb, Celgene Corporation and Janssen, etc.
The global Psoriatic Arthritis Treatment market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Eli Lilly
Roche
Merck
Novartis
Abbvie
Amgen
Bristol Myers Squibb
Celgene Corporation
Janssen
Bausch Health
Global Psoriatic Arthritis Treatment market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Psoriatic Arthritis Treatment market, Segment by Type:
Kits
Reagents
Instruments
Global Psoriatic Arthritis Treatment market, by Application
Hospitals
Clinics
Ambulatory Surgery Centers
Diagnostic Laboratories
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Psoriatic Arthritis Treatment companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The global Psoriatic Arthritis Treatment market size is expected to reach US$ 12040 million by 2029, growing at a CAGR of 5.7% from 2023 to 2029. The market is mainly driven by the significant applications of Psoriatic Arthritis Treatment in various end use industries. The expanding demands from the Hospitals, Clinics, Ambulatory Surgery Centers and Diagnostic Laboratories, are propelling Psoriatic Arthritis Treatment market. Kits, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Reagents segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Psoriatic Arthritis Treatment, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Psoriatic Arthritis Treatment market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Psoriatic Arthritis Treatment market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Psoriatic Arthritis Treatment sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Psoriatic Arthritis Treatment covered in this report include Eli Lilly, Roche, Merck, Novartis, Abbvie, Amgen, Bristol Myers Squibb, Celgene Corporation and Janssen, etc.
The global Psoriatic Arthritis Treatment market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Eli Lilly
Roche
Merck
Novartis
Abbvie
Amgen
Bristol Myers Squibb
Celgene Corporation
Janssen
Bausch Health
Global Psoriatic Arthritis Treatment market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Psoriatic Arthritis Treatment market, Segment by Type:
Kits
Reagents
Instruments
Global Psoriatic Arthritis Treatment market, by Application
Hospitals
Clinics
Ambulatory Surgery Centers
Diagnostic Laboratories
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Psoriatic Arthritis Treatment companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Psoriatic Arthritis Treatment
1.1 Psoriatic Arthritis Treatment Market Overview
1.1.1 Psoriatic Arthritis Treatment Product Scope
1.1.2 Psoriatic Arthritis Treatment Market Status and Outlook
1.2 Global Psoriatic Arthritis Treatment Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Psoriatic Arthritis Treatment Market Size by Region (2018-2029)
1.4 Global Psoriatic Arthritis Treatment Historic Market Size by Region (2018-2023)
1.5 Global Psoriatic Arthritis Treatment Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Psoriatic Arthritis Treatment Market Size (2018-2029)
1.6.1 North America Psoriatic Arthritis Treatment Market Size (2018-2029)
1.6.2 Europe Psoriatic Arthritis Treatment Market Size (2018-2029)
1.6.3 Asia-Pacific Psoriatic Arthritis Treatment Market Size (2018-2029)
1.6.4 Latin America Psoriatic Arthritis Treatment Market Size (2018-2029)
1.6.5 Middle East & Africa Psoriatic Arthritis Treatment Market Size (2018-2029)
2 Psoriatic Arthritis Treatment Market by Type
2.1 Introduction
2.1.1 Kits
2.1.2 Reagents
2.1.3 Instruments
2.2 Global Psoriatic Arthritis Treatment Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Psoriatic Arthritis Treatment Historic Market Size by Type (2018-2023)
2.2.2 Global Psoriatic Arthritis Treatment Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Psoriatic Arthritis Treatment Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Psoriatic Arthritis Treatment Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Psoriatic Arthritis Treatment Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Psoriatic Arthritis Treatment Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Psoriatic Arthritis Treatment Revenue Breakdown by Type (2018-2029)
3 Psoriatic Arthritis Treatment Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Clinics
3.1.3 Ambulatory Surgery Centers
3.1.4 Diagnostic Laboratories
3.2 Global Psoriatic Arthritis Treatment Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Psoriatic Arthritis Treatment Historic Market Size by Application (2018-2023)
3.2.2 Global Psoriatic Arthritis Treatment Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Psoriatic Arthritis Treatment Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Psoriatic Arthritis Treatment Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Psoriatic Arthritis Treatment Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Psoriatic Arthritis Treatment Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Psoriatic Arthritis Treatment Revenue Breakdown by Application (2018-2029)
4 Psoriatic Arthritis Treatment Competition Analysis by Players
4.1 Global Psoriatic Arthritis Treatment Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Psoriatic Arthritis Treatment as of 2022)
4.3 Date of Key Players Enter into Psoriatic Arthritis Treatment Market
4.4 Global Top Players Psoriatic Arthritis Treatment Headquarters and Area Served
4.5 Key Players Psoriatic Arthritis Treatment Product Solution and Service
4.6 Competitive Status
4.6.1 Psoriatic Arthritis Treatment Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Eli Lilly
5.1.1 Eli Lilly Profile
5.1.2 Eli Lilly Main Business
5.1.3 Eli Lilly Psoriatic Arthritis Treatment Products, Services and Solutions
5.1.4 Eli Lilly Psoriatic Arthritis Treatment Revenue (US$ Million) & (2018-2023)
5.1.5 Eli Lilly Recent Developments
5.2 Roche
5.2.1 Roche Profile
5.2.2 Roche Main Business
5.2.3 Roche Psoriatic Arthritis Treatment Products, Services and Solutions
5.2.4 Roche Psoriatic Arthritis Treatment Revenue (US$ Million) & (2018-2023)
5.2.5 Roche Recent Developments
5.3 Merck
5.3.1 Merck Profile
5.3.2 Merck Main Business
5.3.3 Merck Psoriatic Arthritis Treatment Products, Services and Solutions
5.3.4 Merck Psoriatic Arthritis Treatment Revenue (US$ Million) & (2018-2023)
5.3.5 Novartis Recent Developments
5.4 Novartis
5.4.1 Novartis Profile
5.4.2 Novartis Main Business
5.4.3 Novartis Psoriatic Arthritis Treatment Products, Services and Solutions
5.4.4 Novartis Psoriatic Arthritis Treatment Revenue (US$ Million) & (2018-2023)
5.4.5 Novartis Recent Developments
5.5 Abbvie
5.5.1 Abbvie Profile
5.5.2 Abbvie Main Business
5.5.3 Abbvie Psoriatic Arthritis Treatment Products, Services and Solutions
5.5.4 Abbvie Psoriatic Arthritis Treatment Revenue (US$ Million) & (2018-2023)
5.5.5 Abbvie Recent Developments
5.6 Amgen
5.6.1 Amgen Profile
5.6.2 Amgen Main Business
5.6.3 Amgen Psoriatic Arthritis Treatment Products, Services and Solutions
5.6.4 Amgen Psoriatic Arthritis Treatment Revenue (US$ Million) & (2018-2023)
5.6.5 Amgen Recent Developments
5.7 Bristol Myers Squibb
5.7.1 Bristol Myers Squibb Profile
5.7.2 Bristol Myers Squibb Main Business
5.7.3 Bristol Myers Squibb Psoriatic Arthritis Treatment Products, Services and Solutions
5.7.4 Bristol Myers Squibb Psoriatic Arthritis Treatment Revenue (US$ Million) & (2018-2023)
5.7.5 Bristol Myers Squibb Recent Developments
5.8 Celgene Corporation
5.8.1 Celgene Corporation Profile
5.8.2 Celgene Corporation Main Business
5.8.3 Celgene Corporation Psoriatic Arthritis Treatment Products, Services and Solutions
5.8.4 Celgene Corporation Psoriatic Arthritis Treatment Revenue (US$ Million) & (2018-2023)
5.8.5 Celgene Corporation Recent Developments
5.9 Janssen
5.9.1 Janssen Profile
5.9.2 Janssen Main Business
5.9.3 Janssen Psoriatic Arthritis Treatment Products, Services and Solutions
5.9.4 Janssen Psoriatic Arthritis Treatment Revenue (US$ Million) & (2018-2023)
5.9.5 Janssen Recent Developments
5.10 Bausch Health
5.10.1 Bausch Health Profile
5.10.2 Bausch Health Main Business
5.10.3 Bausch Health Psoriatic Arthritis Treatment Products, Services and Solutions
5.10.4 Bausch Health Psoriatic Arthritis Treatment Revenue (US$ Million) & (2018-2023)
5.10.5 Bausch Health Recent Developments
6 North America
6.1 North America Psoriatic Arthritis Treatment Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Psoriatic Arthritis Treatment Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Psoriatic Arthritis Treatment Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Psoriatic Arthritis Treatment Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Psoriatic Arthritis Treatment Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Psoriatic Arthritis Treatment Market Dynamics
11.1 Psoriatic Arthritis Treatment Industry Trends
11.2 Psoriatic Arthritis Treatment Market Drivers
11.3 Psoriatic Arthritis Treatment Market Challenges
11.4 Psoriatic Arthritis Treatment Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
